FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

956231000168105: Duavive 0.45/20 (bazedoxifene 20 mg + conjugated estrogens 450 microgram) modified release tablet (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1956361000168110 Duavive 0.45/20 (bazedoxifene 20 mg + conjugated estrogens 450 microgram) modified release tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1956371000168116 Duavive 0.45/20 modified release tablet en Synonym Active Case sensitive Australian Medicines Terminology module
2655151000168117 Duavive 0.45/20 (bazedoxifene 20 mg + conjugated oestrogens 450 microgram) modified release tablet en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Duavive 0.45/20 modified release tablet Is a trade product unit of use true Inferred relationship Some
Duavive 0.45/20 modified release tablet Is a Duavive 0.45/20 true Inferred relationship Some
Duavive 0.45/20 modified release tablet Is a conjugated estrogens 450 microgram + bazedoxifene 20 mg modified release tablet true Inferred relationship Some
Duavive 0.45/20 modified release tablet has manufactured dose form modified release tablet true Inferred relationship Some
Duavive 0.45/20 modified release tablet has unit of use tablet true Inferred relationship Some 1927860235
Duavive 0.45/20 modified release tablet has Australian BoSS bazedoxifene true Inferred relationship Some 1927860234
Duavive 0.45/20 modified release tablet has intended active ingredient bazedoxifene true Inferred relationship Some 1927860234
Duavive 0.45/20 modified release tablet has Australian BoSS conjugated estrogens true Inferred relationship Some 1891742650
Duavive 0.45/20 modified release tablet has intended active ingredient conjugated estrogens true Inferred relationship Some 1891742650
Inbound Relationships Type Active Source Characteristic Refinability Group
Duavive 0.45/20 (bazedoxifene 20 mg + conjugated estrogens 450 microgram) modified release tablet, 28 tablets, blister pack (containered trade product pack) has TPUU True Duavive 0.45/20 modified release tablet Inferred relationship Some 1
Duavive 0.45/20 modified release tablet, 7, blister pack has TPUU True Duavive 0.45/20 modified release tablet Inferred relationship Some 1
Duavive 0.45/20 (bazedoxifene 20 mg + conjugated estrogens 450 microgram) modified release tablet, 7 tablets (trade product pack) has TPUU True Duavive 0.45/20 modified release tablet Inferred relationship Some 1
Duavive 0.45/20 modified release tablet, 28 has TPUU True Duavive 0.45/20 modified release tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start